InvestSMART

Chimeric Therapeutics Limited (ASX:CHM)

ALERT: Price-sensitive ASX Announcement for CHM
Current share price for CHM : $0.068 0.066 (3,300%)+
Announcement
Release
19 Mar 2026 8:26AM
Price at Release
$0.002
Full Release
download
Summary
Chimeric Therapeutics Limited announced a security consolidation of their ordinary shares and options, scheduled to become effective on April 20, 2026. The consolidation involves a ratio of 100 pre-consolidation securities to 1 post-consolidation security. This affects various securities, including ordinary fully paid shares and options expiring in 2026 and 2028. The trading in the post-consolidation securities will commence on a deferred settlement basis on April 22, 2026, with the record date set for April 23, 2026. The final settlement of trades will occur on May 5, 2026.
Key Points
  • Security consolidation of ordinary shares and options by Chimeric Therapeutics Limited.
  • Consolidation ratio of 100 to 1.
  • Effective date of consolidation is April 20, 2026.
  • Post-consolidation trading commences on April 22, 2026.
  • Record date for consolidation is April 23, 2026.
  • Final settlement of trades on May 5, 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.